Dr. Maegawa’s research laboratory is devoted to developing therapeutic strategies for lysosomal storage diseases (LSDs), inborn organelle diseases caused by mutation in genes encoding mostly enzymes that are essential for lysosomes to function as units of compartmental recycling and degradation.


Lysosomal Storage Disease Program

UF Lysosomal Storage Disease Program is committed to offering a comprehensive and personalized clinical care for patients suffering from lysosomal storage diseases (LSDs).

A student in the College of Nursing's online Nurse Practioner program completes her clinical studies at Gainesville's Eastside Clinic.


Identifying Small Molecule Therapies by HTS Assays Using LSD Patient Cells

We are developing robust high-throughput screening (HTS) cell-based assays using directly patient cell lines to screen selected libraries of drug-like compounds that enhance the residual activity of specific misfolded mutant enzymes.

Investigation of Pathogenic Cascades in LSDs as Potential Therapeutic Targets

we are currently establishing fibroblast-derived induced-neuronal (iN) cells from patients with LSDs. The iN cells from LSD will be crucial to investigate pathogenic cascades of neurological relevance. The aim is to investigate to confirm LMP in different LSDs and investigate the molecular mechanisms causing LMP and its downstream events in iN cells from LSD patients.

LSD Clinical Studies

Several clinical studies related to the natural history of different LSD and early and late phase clinical trials in collaboration different pharmaceuticals. Most subjects are evaluated and recruited for the studies in clinic.

UF Pediatric News

Pediatricians encouraged to discuss gun safety

Following backlash and support, school board extends mask mandate in Alachua County Public Schools

Alachua County schools see COVID-19 infections, exposures drop

Protect your family this flu season by getting vaccinated